NextCure, Inc. (NXTC) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by NextCure, Inc. on February 3, 2025, regarding an event dated January 31, 2025. The Company is a Delaware corporation with its principal executive offices in Beltsville, Maryland, and its common stock trades on the Nasdaq Global Select Market under the symbol "NXTC".
Key Financial Metrics
The filing does not provide specific financial data regarding revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a regulatory compliance matter related to the Company's stock price.
Material Changes and Events
On January 31, 2025, the Company received written notice from Nasdaq stating that the closing price of its common stock had fallen below $1.00 per share for 30 consecutive business days. This constitutes a failure to satisfy the Minimum Bid Requirement under Nasdaq Listing Rule 5450(a)(1).
Outlook, Risks, and Management Commentary
- Compliance Timeline: The Company has been granted a 180-calendar-day Grace Period, ending July 30, 2025, to regain compliance.
- Compliance Criteria: To regain compliance, the closing bid price must be at least $1.00 per share for a minimum of ten consecutive business days within the Grace Period.
- Extension Possibility: If compliance is not achieved by the end of the Grace Period, the Company may be eligible for an additional 180-day period, provided it meets other listing standards (excluding the bid price) and notifies Nasdaq of its intent to cure the deficiency, potentially via a reverse stock split.
- Delisting Risk: If the Company fails to cure the deficiency or meet other listing standards, Nasdaq may issue a delisting notice. The Company retains the right to appeal such a determination.
- Management Action: Management intends to actively monitor the stock price and evaluate options, including a reverse stock split, to regain compliance. There is no assurance that compliance will be achieved.
- Immediate Impact: The notice has no immediate effect on the listing or trading of the Company's common stock.
Key Facts for Investor Verification
- Verify the current trading price of NXTC to assess the likelihood of meeting the $1.00 threshold within the Grace Period.
- Monitor future filings for announcements regarding a potential reverse stock split.
- Review the Company's cash position and capital resources to determine if a reverse stock split or other capital raising activities are feasible.
- Check for any subsequent communications from Nasdaq regarding the status of the compliance period.